Does TRANDOLAPRIL Cause Focal segmental glomerulosclerosis? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Focal segmental glomerulosclerosis have been filed in association with TRANDOLAPRIL (Trandolapril). This represents 2.6% of all adverse event reports for TRANDOLAPRIL.
16
Reports of Focal segmental glomerulosclerosis with TRANDOLAPRIL
2.6%
of all TRANDOLAPRIL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From TRANDOLAPRIL?
Of the 16 reports.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANDOLAPRIL. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does TRANDOLAPRIL Cause?
Dyspnoea (87)
Psychotic disorder (81)
Cough (76)
Fatigue (60)
Pneumonia (58)
Hypertension (57)
Asthma (56)
Hypotension (48)
Hallucination, auditory (46)
Paranoia (46)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which TRANDOLAPRIL Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
TRANDOLAPRIL vs TRANDOLAPRIL\VERAPAMIL
TRANDOLAPRIL vs TRANEXAMIC ACID
TRANDOLAPRIL vs TRANYLCYPROMINE
TRANDOLAPRIL vs TRASTUZUMAB
TRANDOLAPRIL vs TRASTUZUMAB-ANNS